Literature DB >> 19326326

Induction of chemoprotective phase 2 enzymes by ginseng and its components.

Lawrence S Lee1, Katherine K Stephenson, Jed W Fahey, Teresa L Parsons, Paul S Lietman, Adriana S Andrade, Xiaoguang Lei, Heedong Yun, Gaik H Soon, Ping Shen, Samuel Danishefsky, Charles Flexner.   

Abstract

Phase 2 detoxification enzymes protect against carcinogenesis and oxidative stress. Ginseng ( PANAX spp.) extracts and components were assayed for inducer activity of NQO1 (quinone reductase), a phase 2 enzyme, in Hepa1c1c7 cells. Ginseng extracts were analyzed for ginsenosides and panaxytriol. Korean red PANAX GINSENG extracts demonstrated the most potent phase 2 enzyme induction activity (76,900 U/g dried rhizome powder and 27,800 U/g for two similar preparations). The ginsenoside-enriched HT-1001 American ginseng ( PANAX QUINQUEFOLIUS) extract was the next most potent inducer, with activity of 15,900 U/g, followed by raw American ginseng root with activity of 8700 U/g. Neither a polysaccharide-enriched extract of American ginseng nor a commercial white PANAX GINSENG preparation showed any inducer activity. Pure ginsenosides showed no inducer activity. Protopanaxadiol and protopanaxatriol, deglycosylated ginsenoside metabolic derivatives, showed potent induction activity (approximately 500,000 U/g each). Synthetic panaxytriol was over 10-fold more potent (induction potency 5,760,000 U/g). There was no correlation between ginsenoside content and phase 2 enzyme induction. The most potent inducing red ginseng extract also had the highest panaxytriol content, 120.8 microg/g. We found that ginseng induced NQO1 and that polyacetylenes are the most active components. Georg Thieme Verlag KG Stuttgart.New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19326326     DOI: 10.1055/s-0029-1185508

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

Review 1.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

2.  Anti-cancer and potential chemopreventive actions of ginseng by activating Nrf2 (NFE2L2) anti-oxidative stress/anti-inflammatory pathways.

Authors:  Constance Lay-Lay Saw; Qing Wu; Ah-Ng Tony Kong
Journal:  Chin Med       Date:  2010-10-27       Impact factor: 5.455

3.  Dissipation, Processing Factors and Dietary Risk Assessment for Flupyradifurone Residues in Ginseng.

Authors:  Nan Fang; Changpeng Zhang; Zhongbin Lu; Zhou Lu; Zhongbei Zhang; Bo Wang; Zhiguang Hou; Xueping Zhao
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

Review 4.  Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites.

Authors:  Xiao-Jia Chen; Xiao-Jing Zhang; Yan-Mei Shui; Jian-Bo Wan; Jian-Li Gao
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-30       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.